AP2009004840A0 - Compounds and methods for treatment of HCV - Google Patents

Compounds and methods for treatment of HCV

Info

Publication number
AP2009004840A0
AP2009004840A0 AP2009004840A AP2009004840A AP2009004840A0 AP 2009004840 A0 AP2009004840 A0 AP 2009004840A0 AP 2009004840 A AP2009004840 A AP 2009004840A AP 2009004840 A AP2009004840 A AP 2009004840A AP 2009004840 A0 AP2009004840 A0 AP 2009004840A0
Authority
AP
ARIPO
Prior art keywords
hcv
compounds
treatment
methods
Prior art date
Application number
AP2009004840A
Other languages
English (en)
Inventor
Angela Lam
Qiang Zhu
Yun Liao
Original Assignee
Xtl Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xtl Biopharmaceuticals Ltd filed Critical Xtl Biopharmaceuticals Ltd
Publication of AP2009004840A0 publication Critical patent/AP2009004840A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2009004840A 2006-10-13 2007-10-15 Compounds and methods for treatment of HCV AP2009004840A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85164306P 2006-10-13 2006-10-13
US92552807P 2007-04-20 2007-04-20
US93356507P 2007-06-06 2007-06-06
PCT/US2007/022055 WO2008048589A2 (fr) 2006-10-13 2007-10-15 Composés et procédés pour le traitement du virus de l'hépatite c

Publications (1)

Publication Number Publication Date
AP2009004840A0 true AP2009004840A0 (en) 2009-04-30

Family

ID=39314638

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004840A AP2009004840A0 (en) 2006-10-13 2007-10-15 Compounds and methods for treatment of HCV

Country Status (8)

Country Link
US (1) US7923004B2 (fr)
EP (1) EP2076264A2 (fr)
JP (1) JP2010506843A (fr)
AP (1) AP2009004840A0 (fr)
AU (1) AU2007313250A1 (fr)
CA (1) CA2680507A1 (fr)
EA (1) EA200970375A1 (fr)
WO (1) WO2008048589A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329703B2 (en) * 2005-02-15 2012-12-11 Xtl Biopharmaceuticals Ltd. Pyrazole compounds
RU2544010C2 (ru) 2009-02-27 2015-03-10 Энанта Фармасьютикалс, Инк. Ингибиторы вируса гепатита с
WO2011015657A1 (fr) 2009-08-07 2011-02-10 Tibotec Pharmaceuticals Dérivés de phényléthynyle en tant qu'inhibiteurs du virus de l'hépatite c
WO2011015658A1 (fr) 2009-08-07 2011-02-10 Tibotec Pharmaceuticals Dérivés de bis-benzimidazole en tant qu'inhibiteurs du virus de l'hépatite c
AU2010291215A1 (en) 2009-09-03 2012-02-23 Janssen Sciences Ireland Uc Bis-benzimidazole derivatives
UA108211C2 (uk) 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
US8653070B2 (en) 2009-12-14 2014-02-18 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
US20130296311A1 (en) * 2010-05-28 2013-11-07 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
AR081848A1 (es) * 2010-06-09 2012-10-24 Presidio Pharmaceuticals Inc Inhibidores de la proteina ns5a del vhc
CN103180310B (zh) 2010-07-26 2015-11-25 爱尔兰詹森科学公司 作为hcv抑制剂的杂二环衍生物
WO2013030750A1 (fr) 2011-09-01 2013-03-07 Lupin Limited Composés antiviraux
AU2012360910B8 (en) 2011-12-28 2017-02-02 Janssen Sciences Ireland Uc Quinazolinone derivatives as HCV inhibitors
MX340033B (es) 2011-12-28 2016-06-21 Janssen Sciences Ireland Uc Derivados heterobiciclicos como inhibidores del virus de la hepatitis c.
AU2013217224B2 (en) 2012-02-10 2017-04-06 Lupin Limited Antiviral compounds with a dibenzooxaheterocycle moiety
KR102835299B1 (ko) 2018-12-04 2025-07-18 브리스톨-마이어스 스큅 컴퍼니 다중 동위원소체 반응 모니터링에 의한 샘플내 보정 곡선을 사용한 분석 방법
WO2020149553A1 (fr) * 2019-01-15 2020-07-23 주식회사 보로노이 Dérivé d'aryle ou d'hétéroaryle, et composition pharmaceutique le comprenant en tant que principe actif pour le traitement d'une maladie associée à une kinase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
HU9301218D0 (en) * 1992-05-13 1993-08-30 Sandoz Ag Method for producing new pyrazole derivatives
AU7319100A (en) * 1999-09-24 2001-04-24 Agro-Kanesho Co. Ltd. Insecticidal and acaricidal agents
DE10064823A1 (de) 2000-12-22 2002-06-27 Knoll Ag Integrinrezeptorliganden
US20020183366A1 (en) * 2001-03-23 2002-12-05 Garvey David S. Cyclooxygenase-2 inhibitors, compositions and methods of use
CH697574B1 (de) * 2003-01-07 2008-12-15 Lanxess Deutschland Gmbh Pyrazolylarylalkine.
CH697663B1 (de) * 2003-01-07 2009-01-15 Lanxess Deutschland Gmbh Pyrazolylalkine.
KR101076018B1 (ko) * 2003-01-08 2011-10-21 유니버시티 오브 워싱톤 항균제
EP1522541A1 (fr) 2003-10-07 2005-04-13 Lipideon Biotechnology AG Nouveaux composés hypocholesterolémiques
WO2006028524A2 (fr) 2004-04-29 2006-03-16 Pharmix Corporation Compositions et traitements pour l'inhibition de kinase et/ou de hmg-coa reductase
WO2006019831A1 (fr) * 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Procedes pour le traitement de l'hepatite c
JP2006089485A (ja) * 2004-08-24 2006-04-06 Santen Pharmaceut Co Ltd ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
US8329703B2 (en) * 2005-02-15 2012-12-11 Xtl Biopharmaceuticals Ltd. Pyrazole compounds

Also Published As

Publication number Publication date
WO2008048589A3 (fr) 2008-12-04
JP2010506843A (ja) 2010-03-04
AU2007313250A1 (en) 2008-04-24
EP2076264A2 (fr) 2009-07-08
CA2680507A1 (fr) 2008-04-24
US20090041723A1 (en) 2009-02-12
US7923004B2 (en) 2011-04-12
WO2008048589A2 (fr) 2008-04-24
EA200970375A1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
AP2009004840A0 (en) Compounds and methods for treatment of HCV
IL193460A0 (en) Compounds and methods for treatment of stroke
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2032131A4 (fr) Procédé de traitement
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
IL194820A0 (en) Devices and methods for treatment of tissue
EP2043727A4 (fr) Dispositifs et procédés destinés au traitement de l'obésité
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
ZA200901364B (en) Method of treatment of photodermatoses
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP2007381A4 (fr) Compositions e procédés d'utilisation de ritonavir pour le traitement du virus de l'hépatite c
IL197305A0 (en) Methods of treatment for ulcerative colitis
GB0610746D0 (en) Method of treatment
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
IL226363A0 (en) Compounds and methods for treating cancer
GB0426196D0 (en) Methods of treatment
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
GB2441094B (en) Methods for treatment and prevention of infection
ZA200902434B (en) Compounds and methods for treatment of HCV
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1962882A4 (fr) Préparations et méthodes pour le traitement du diabète
GB0504657D0 (en) Compositions and methods of treatment